Medtronic Diabetes

Medtronic Diabetes is a division of Medtronic plc, dedicated to advancing diabetes care through innovative medical devices and digital solutions. With a legacy that began in 1983, the division is known for its pioneering work in insulin pump technology and continuous glucose monitoring systems. Medtronic Diabetes is set to become a standalone company named MiniMed, reflecting its commitment to improving diabetes management and enhancing patients' quality of life. Headquartered in Northridge, California, Medtronic Diabetes employs over 8,000 people and generates around $2.8 billion in annual revenue. The company offers a range of products, including the MiniMed 780G insulin pump, smart continuous glucose monitors like Simplera Sync, and the InPen smart insulin pen. Its integrated diabetes management ecosystem combines hardware, software, and telehealth services to provide real-time monitoring and personalized care. Medtronic Diabetes serves individuals with Type 1 and Type 2 diabetes, as well as healthcare providers, aiming to simplify diabetes care and improve treatment outcomes.

• Employees 1100
• Founded 2001
• Total Funding $30500000